A systematic review finds that a ketamine-morphine combination enhances pain relief in acute trauma, suggesting improved emergency care practices.
Background and Aims: Acute trauma pain often remains inadequately treated despite opioid therapy. Low-dose ketamine has emerged as a promising adjunct analgesic that may enhance morphine effectiveness while reducing opioid requirements. This systematic review assessed the efficacy and safety of morphine combined with low-dose ketamine versus morphine alone for acute trauma analgesia. Material and Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, comprehensive searches were conducted across six databases (2006–2024) for studies comparing morphine–ketamine combination versus morphine monotherapy in acute trauma patients. Six eligible randomized controlled trials (RCTs) ( n = 708) were included. Meta-analysis was performed using RevMan 5.4 software with random-effects modeling. Results: Six RCTs involving 708 patients from emergency departments and prehospital settings were analyzed. Morphine–ketamine combination demonstrated superior analgesic efficacy with significantly lower final pain scores (mean difference (MD): –0.26; 95% confidence interval (CI): –0.40 to –0.12; P = 0.0003). Subgroup analysis by ketamine dose indicated the most pronounced and statistically significant pain reduction at 0.3 mg/kg (MD: –0.30; 95% CI: –0.48 to –0.12; P = 0.001), while lower doses showed similar trends. Significant pain reduction occurred at 30 min after sensitivity analysis (MD: −0.64, P < 0.00001) and sustained through 60 min (MD: −0.32, P < 0.0001). The combination reduced total morphine consumption by 2.93 mg ( P = 0.07). Overall, adverse events increased (odds ratio: 2.37, P = 0.05), but specific events—nausea, vomiting, and hallucinations—showed no significant differences between groups. No serious adverse events occurred. Conclusion: Low-dose ketamine as a morphine adjunct improves acute trauma pain control, shows a trend toward reduced opioid requirements, and maintains an acceptable safety profile, supporting its clinical implementation in emergency settings.
No takes yet. Share an insight, caveat, or question.
Alverina et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: